Bridgeway Capital Management’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $280K | Hold |
|
|||||
|
2025
Q1 | $484K | Buy |
|
|||||
|
2024
Q4 | $341K | Sell |
|
|||||
|
2024
Q3 | $187K | Hold |
|
|||||
|
2024
Q2 | $215K | Hold |
|
|||||
|
2024
Q1 | $232K | Sell |
|
|||||
|
2023
Q4 | $372K | Buy |
|
|||||
|
2023
Q3 | $264K | Hold |
|
|||||
|
2023
Q2 | $318K | Buy |
|
|||||
|
2023
Q1 | $281K | Hold |
|
|||||
|
2022
Q4 | $183K | Hold |
|
|||||
|
2022
Q3 | $139K | Sell |
|
|||||
|
2022
Q2 | $173K | Buy |
|
|||||
|
2022
Q1 | $31K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $78K | Sell |
|
|||||
|
2021
Q2 | $752K | Buy |
|
|||||
|
2021
Q1 | $1.35M | Buy |
|
|||||
|
2020
Q4 | $772K | Hold |
|
|||||
|
2020
Q3 | $823K | Buy |
|
|||||
|
2020
Q2 | $661K | Buy |
|
|||||
|
2020
Q1 | $210K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $42K | Hold |
|
|||||
|
2019
Q2 | $95K | Hold |
|
|||||
|
2019
Q1 | $89K | Hold |
|
|||||
|
2018
Q4 | $63K | Hold |
|
|||||
|
2018
Q3 | $147K | Hold |
|
|||||
|
2018
Q2 | $87K | Sell |
|
|||||
|
2018
Q1 | $163K | Hold |
|
|||||
|
2017
Q4 | $200K | Hold |
|
|||||
|
2017
Q3 | $176K | Hold |
|
|||||
|
2017
Q2 | $253K | Hold |
|
|||||
|
2017
Q1 | $412K | Hold |
|
|||||
|
2016
Q4 | $135K | Hold |
|
|||||
|
2016
Q3 | $169K | Hold |
|
|||||
|
2016
Q2 | $194K | Sell |
|
|||||
|
2016
Q1 | $294K | Hold |
|
|||||
|
2015
Q4 | $357K | Hold |
|
|||||
|
2015
Q3 | $412K | Buy |
|
|||||
|
2015
Q2 | $638K | Buy |
|
|||||
|
2015
Q1 | $535K | Buy |
|
|||||
|
2014
Q4 | $458K | Buy |
|
|||||
|
2014
Q3 | $484K | Buy |
|